Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DALARI: Rifampicin-Clindamycin Interaction
NCT02782078Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of clindamycin and rifampicin in Staphylococcal osteoarticular infection, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Clindamycin Area Under Curve at Day 14. Started Mar 2017; status: completed.
02
Drugs
clindamycinrifampicin
03
Conditions
Staphylococcal osteoarticular infection
Beyond the preview
Go deeper on NCT02782078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02782078.